Stephens Claudester, Francis Stephen J, Abell Virginia, DiPersio Joseph R, Wells Patricia
Summa Health System, Akron, OH 44309-2090, USA.
Am J Infect Control. 2007 May;35(4):212-5. doi: 10.1016/j.ajic.2006.04.208.
Acinetobacter baumannii is a gram-negative, coccobacillus found in water and is a significant nosocomial pathogen in hospitals. This report chronicles the appearance in June 2003 of a multidrug-resistant A baumannii (MDR-AB) strain, its dissemination, and interventions used to control it in an acute care hospital (ACH) and long-term acute care facility (LTAC).
Molecular typing using pulsed-field gel electrophoresis (PFGE) showed that 88 of 99 strains (89%) gave an identical banding designated as clone A. Eight additional isolates were variants of clone A, and 3 isolates were unrelated.
A baumannii was isolated from 229 patients between January 2003 and December 2004. Of these patients, 151 (66%) were colonized/infected with MDR-AB. Most isolates were resistant to antibiotics except for imipenem and ampicillin/sulbactam. Isolates included 108 (72%) in the respiratory tract, 32 (21%) in wounds, 6 (4%) in blood, and 5 (3%) in urine. Most isolates were found in the LTAC (70 isolates), ICU step-down (27 isolates), and ICU (26 isolates).
This epidemiologic history illustrates (1) epidemic clonal spread, (2) target populations, (3) variable monthly prevalence, and (4) intervention outcomes. With intervention, the number of new isolates in the ACH decreased by dedicating an infection control professional to critical care, daily surveillance, isolation of positive MDR-AB patients, universal gloving, and routinely reporting results.
鲍曼不动杆菌是一种革兰氏阴性球杆菌,存在于水中,是医院中一种重要的医院感染病原体。本报告记录了2003年6月出现的一株多重耐药鲍曼不动杆菌(MDR-AB)菌株、其传播情况以及在一家急症医院(ACH)和长期急性护理机构(LTAC)中用于控制它的干预措施。
使用脉冲场凝胶电泳(PFGE)进行分子分型显示,99株菌株中有88株(89%)呈现相同的条带模式,被指定为克隆A。另外8株分离株是克隆A的变体,3株分离株无关。
2003年1月至2004年12月期间从229名患者中分离出鲍曼不动杆菌。在这些患者中,151例(66%)被MDR-AB定植/感染。除亚胺培南和氨苄西林/舒巴坦外,大多数分离株对其他抗生素耐药。分离株包括呼吸道中的108株(72%)、伤口中的32株(21%)、血液中的6株(4%)和尿液中的5株(3%)。大多数分离株发现于LTAC(70株)、ICU后送病房(27株)和ICU(26株)。
这一流行病学史说明了(1)流行克隆传播、(2)目标人群、(3)每月患病率的变化以及(4)干预结果。通过干预,ACH中新分离株的数量减少,具体措施包括为重症监护配备感染控制专业人员、每日监测、隔离MDR-AB阳性患者、普遍戴手套以及定期报告结果。